American Society of Hematology (ASH) Meeting on Hematologic Malignancies 2016

American Society of Hematology (ASH) Meeting on Hematologic Malignancies 2016 is a conference dedicated to the latest developments in clinical care of hematologic malignancies with evidence-based treatment approaches, ranging from standard of care, specialized disease complications, and novel agent discussions as well as "How I Treat" sessions on core malignancies, including

• Lymphoma
• Leukemia
• Myeloma
• Myelodysplastic syndromes
• Myeloproliferative neoplasms

American Society of Hematology (ASH) Meeting on Hematologic Malignancies 2016 brings together:

• Clinical researchers
• Clinicians in practice (including advanced practice professionals)
• Fellows in training